Robert William Moses
Keine laufenden Positionen mehr
Vermögen: 498 180 $ am 31.03.2024
Profil
Robert William Moses served as Chairman of CSL Innovation Pty Ltd., Meditech Research Ltd., Australian Stem Cell Centre Ltd., and Freehills.
He was also the Corporate Vice President of CSL Ltd.
and the Corporate Manager-New Business Development of Orica Ltd.
Moses was an Independent Non-Executive Chairman of Percheron Therapeutics Ltd.
from 2012 to 2021 and Chairman of TGR BioSciences Pty Ltd.
in 2011-2012.
He received his undergraduate degree from Oberlin College and his MBA from The University of Chicago.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.09.2022 | 9 200 000 ( 1,02% ) | 498 180 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Robert William Moses
| Unternehmen | Position | Ende |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Chairman | 15.12.2021 |
| ZENYTH THERAPEUTICS LIMITED | Chairman | - |
| Australian Stem Cell Centre Ltd. | Chairman | - |
Meditech Research Ltd.
 Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Chairman | - |
Polymers CRC Ltd.
 Polymers CRC Ltd. Miscellaneous Commercial ServicesCommercial Services Polymers CRC Ltd. provides polymer research services. It offers research on health therapies and delivery, water and food security and polymer solar cells. The company was founded in 1992 and is headquartered in Notting Hill, Australia. | Director/Board Member | - |
Ausbildung von Robert William Moses
| Oberlin College | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| CSL LIMITED | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| ORICA LIMITED | Process Industries |
| Private Unternehmen | 6 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
Meditech Research Ltd.
Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Health Technology |
| Freehills | Commercial Services |
Polymers CRC Ltd.
Polymers CRC Ltd. Miscellaneous Commercial ServicesCommercial Services Polymers CRC Ltd. provides polymer research services. It offers research on health therapies and delivery, water and food security and polymer solar cells. The company was founded in 1992 and is headquartered in Notting Hill, Australia. | Commercial Services |
| Australian Stem Cell Centre Ltd. | |
TGR BioSciences Pty Ltd.
 TGR BioSciences Pty Ltd. Medical DistributorsDistribution Services TGR BioSciences Pty Ltd. engages in the development of drug discovery technologies and products. Its products include captsure technology, Elisa one, surefire, alpha surefire and alpha surefire ultra multiplex. The company was founded by Leanna C. Read in 2001 and is headquartered in Thebarton, SA. | Distribution Services |
